PIPELINE
OB001
OB001 is a preclinical peptide program derived from adiponectin biology. We engineer bioactive, post-translationally modified adiponectin-derived domains to target obesity and downstream metabolic dysfunction with a translation-first biomarker strategy.
Adiponectin biology is linked to metabolic homeostasis and inflammation. OB001 focuses on capturing activity that depends on structural features and complex post-translational modifications—then translating that biology into a manufacturable peptide therapeutic.
OB001 is enabled by an in-house chemical biosynthesis platform that supports stereoselective glycan synthesis and ligation chemistry—unlocking complex peptide/protein architectures not easily accessible via standard recombinant workflows.
We share full figures and protocols with qualified partners.